Screening for Prostate Cancer in African American Men – Judd Moul

Judd Moul reviews the history of the U.S. Preventative Services Task Force screening guidelines and highlights the US trends and patterns of disparities in cancer mortality among U.S. counties from 1980 to 2014. Full Video online at UroToday July 12 2018. Our transcript, August 7 2018, is from the section Moul calls “the bottom line.”

Judd Moul MD
Judd Moul MD

“There have been no randomized trials of prostate cancer screening for black men. The only 2 randomized screening trials (one in Europe, one in the USA) included very few African American men.聽 And one of the things that really bothers me … Why hasn’t there been … a true randomized trial focusing on African American men, to answer the question … “Is it beneficial to screen for prostate cancer in this high risk group? What is the proper age to initiate screening for African American men? Is it 40, 45, 50, or is it 55? We don’t know that, it’s only speculation. Continue reading “Screening for Prostate Cancer in African American Men – Judd Moul”

RESPOND is the First Large-Scale Study on African-American Men with Prostate Cancer

August 3, PSA Rising. African American men are more likely to develop prostate cancer than men of any other race and the disease is often more aggressive when diagnosed.

Now, African American touched by prostate cancer are being asked to join an ambitious study to find out why African-American men are at higher risk for developing more aggressive forms of prostate cancer and why they are more likely to die from it.

African American prostate cancer patient-survivors invited to join RESPOND study.ivors invited to join RESPOND study
Facing prostate cancer together. African American prostate cancer patient-survivors invited to join nationwide RESPOND study. Photo source: newsroom: Rutgers Cancer Institute of New Jersey

Called RESPOND, this nationwide study aims to attract 10,000 African-American men聽 to participate. The $26.5 million effort will look at the role of social stressors and genetics in the development of prostate cancer in African-American men. Continue reading “RESPOND is the First Large-Scale Study on African-American Men with Prostate Cancer”